Interruption of Chagas disease transmission in the Andean countries: Colombia.

نویسندگان

  • F Guhl
  • G A Vallejo
چکیده

From a total population of 360 million people living in areas endemic for Chagas disease, it is estimated that at least 100 million are exposed to the risk of infection, and that 16 to 18 million are currently infected with the causative agent, Trypanosoma cruzi. According to estimates in 1991 by the World Health Organization, approximately 500,000 people become infected each year in the absence of control programmes, and 300,000 out of this number are children. The mortality rate can reach 5 to 15% during the initial acute phase of the infection. In Colombia, the first case of Chagas disease was reported in 1929. Since then, numerous studies have contributed to our epidemiological knowledge (Marinkelle 1975), and it is now estimated that there are 1,3 million infected people in the country, with a further 3,6 million people considered at risk since they live in regions known to harbour the domestic insect vectors. Fig. 1 shows the vectorial transmission areas in Colombia, with estimates of their different risk levels. Twenty species of triatomine vectors have been reported in Colombia. The most important in epidemiological terms are those that live in close association with humans, living in cracks and crevices of rural dwellings and emerging at night to suck the blood of the sleeping occupants. Rhodnius prolixus, is the main domestic vector in Colombia, followed in importance by Triatoma dimidata and T. maculata. Other species such as R. robustus, R. brethesi, R. pallescens and T. venosa are generally silvatic in habit, rarely coming in contact with humans and so of lesser epidemiological significance (D’Alessandro et al. 1981). The importance of each species as a vector of T. cruzi depends on several factors, such as geographical distribution, density of domestic or peridomestic populations, preference for feeding on humans or other domestic vertebrates, feeding frequency, susceptibility to the infection, and capacity to produce the infective metacyclic trypomastigote forms of T. cruzi. All these factors, taken as a whole, are important for the implementation of vector control programmes and epidemiological surveillance of Chagas disease transmission. The insect vectors probably account for over 90% of transmission of T.cruzi to humans, but transmission can also occur via blood transfusion from infected donors. This is also important in Colombia where an average of 450,000 bloodunits/year are used, and the prevalence of the infection in blood donors ranges from an average of 3.3% in endemic areas, to 1.3% in non-endemic areas.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Andean subregional Chagas disease area and the Andean initiative of Chagas disease.

The Andean subregional Chagas disease area and the Andean initiative of Chagas disease consist of the association of Peru, Ecuador, Colombia, and Venezuela with their own and particular characteristics: 1. extensive area distributed in a broad latitude; 2. important echo-biological diversity; 3. biogeographically variables due to diverse altitude and latitude; 4. different epidemiological situa...

متن کامل

Chagas disease in Andean countries.

The Andean Countries' Initiative (ACI) for controlling Chagas disease was officially created in 1997 within the framework of the Hipolito Unanue Agreement (UNANUE) between the Ministries of Health of Colombia, Ecuador, Peru, and Venezuela. Its objective was to interrupt transmission via vector and transfusion in the region, taking into account that there are 12.5 million people at risk in the f...

متن کامل

The evolution of Chagas disease (American trypanosomiasis) control after 90 years since Carlos Chagas discovery.

Chagas disease is one of the most serious parasitic diseases of Latin America, with a social and economic impact far outweighing the combined effects of other parasitic diseases such as malaria, leishmaniasis and schistosomiasis. Serological data indicate well over 16 million people are infected with the causative agent, Trypanosoma cruzi, with a further 100 million people considered at risk (W...

متن کامل

Modelling historical changes in the force-of-infection of Chagas disease to inform control and elimination programmes: application in Colombia

Background WHO's 2020 milestones for Chagas disease include having all endemic Latin American countries certified with no intradomiciliary Trypanosoma cruzi transmission, and infected patients under care. Evaluating the variation in historical exposure to infection is crucial for assessing progress and for understanding the priorities to achieve these milestones. Methods Focusing on Colombia,...

متن کامل

Chagas disease: current epidemiological trends after the interruption of vectorial and transfusional transmission in the Southern Cone countries.

Chagas disease, named after Carlos Chagas who first described it in 1909, exists only on the American Continent. It is caused by a parasite, Trypanosoma cruzi, transmitted to humans by blood-sucking triatomine bugs and by blood transfusion. Chagas disease has two successive phases, acute and chronic. The acute phase lasts 6 to 8 weeks. After several years of starting the chronic phase, 20% to 3...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Memorias do Instituto Oswaldo Cruz

دوره 94 Suppl 1  شماره 

صفحات  -

تاریخ انتشار 1999